NYSE: CNC | Healthcare / Healthcare Plans / USA |
64.96 | +0.7200 | +1.12% | Vol 3.37M | 1Y Perf -10.72% |
Apr 16th, 2021 16:04 DELAYED |
BID | 64.48 | ASK | 65.50 | ||
Open | 64.47 | Previous Close | 64.24 | ||
Pre-Market | - | After-Market | 64.80 | ||
- - | -0.16 -0.25% |
Target Price | 78.73 | Analyst Rating | Strong Buy 1.03 | |
Potential % | 21.20 | Finscreener Ranking | ★★★★+ 56.30 | |
Insiders Trans % 3/6/12 mo. | -33/-83/-94 | Value Ranking | ★★★+ 53.20 | |
Insiders Value % 3/6/12 mo. | -98/-100/-100 | Growth Ranking | ★★★★ 60.84 | |
Insiders Shares Cnt. % 3/6/12 mo. | -97/-100/-100 | Income Ranking | — - | |
Market Cap | 37.78B | Earnings Rating | Buy | |
Price Range Ratio 52W % | 53.84 | Earnings Date | 27th Apr 2021 |
Today's Price Range 64.0665.15 | 52W Range 53.6074.70 | 5 Year PE Ratio Range 14.0032.40 |
Summary:
Buy
Technical Indicators: | Neutral |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | 3.75% | ||
1 Month | 4.96% | ||
3 Months | 1.52% | ||
6 Months | -1.89% | ||
1 Year | -10.72% | ||
3 Years | 15.89% | ||
5 Years | 121.71% | ||
10 Years | 695.59% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 10.71 | |||
ROE last 12 Months | 9.17 | |||
ROA (5Y Avg) | 2.01 | |||
ROA last 12 Months | 3.19 | |||
ROC (5Y Avg) | 8.11 | |||
ROC last 12 Months | 7.79 | |||
Return on invested Capital Q | 0.27 | |||
Return on invested Capital Y | 6.48 | |||
Assets Turnover | 1.50 | |||
Receivables Turnover | 10.00 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
20.10 | ||||
1.39 | ||||
0.43 | ||||
6.50 | ||||
8.80 | ||||
9.50 | ||||
-28.25 | ||||
44.31 | ||||
41.73B | ||||
Forward PE | 10.73 | |||
PEG | 1.65 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.00 | ||||
1.10 | ||||
0.41 | ||||
0.71 | ||||
4.80 | ||||
Leverage Ratio | 2.70 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
7.60 | ||||
3.20 | ||||
4.30 | ||||
1.90 | ||||
2.12 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
85.09B | ||||
146.31 | ||||
29.96 | ||||
31.51 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q04 2020 | 0.45 | 0.46 | 2.22 |
Q03 2020 | 0.96 | 1.26 | 31.25 |
Q02 2020 | 2.41 | 2.40 | -0.41 |
Q01 2020 | 1.02 | 0.86 | -15.69 |
Q04 2019 | 0.74 | 0.73 | -1.35 |
Q03 2019 | 0.95 | 0.96 | 1.05 |
Q02 2019 | 1.24 | 1.34 | 8.06 |
Q01 2019 | 1.32 | 1.39 | 5.30 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
3/2021 QR | 1.49 | 3.47 | Positive |
6/2021 QR | 1.85 | 0.00 | - |
12/2021 FY | 5.19 | 0.39 | Positive |
12/2022 FY | 5.83 | -0.51 | Negative |
Next Report Date | 27th Apr 2021 |
Estimated EPS Next Report | 1.49 |
Estimates Count | 8 |
EPS Growth Next 5 Years % | 12.20 |
Volume Overview | |
---|---|
Volume | 3.37M |
Shares Outstanding | 581.59M |
Trades Count | 28.96K |
Dollar Volume | 253.60M |
Avg. Volume | 3.55M |
Avg. Weekly Volume | 3.09M |
Avg. Monthly Volume | 3.12M |
Avg. Quarterly Volume | 3.42M |
Centene Corporation (NYSE: CNC) stock closed at 64.96 per share at the end of the most recent trading day (a 1.12% change compared to the prior day closing price) with a volume of 3.40M shares and market capitalization of 37.78B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 71300 people. Centene Corporation CEO is Michael F. Neidorff.
The one-year performance of Centene Corporation stock is -10.72%, while year-to-date (YTD) performance is 8.21%. CNC stock has a five-year performance of 121.71%. Its 52-week range is between 53.6 and 74.7, which gives CNC stock a 52-week price range ratio of 53.84%
Centene Corporation currently has a PE ratio of 20.10, a price-to-book (PB) ratio of 1.39, a price-to-sale (PS) ratio of 0.43, a price to cashflow ratio of 6.50, a PEG ratio of 2.32, a ROA of 3.19%, a ROC of 7.79% and a ROE of 9.17%. The company’s profit margin is 2.12%, its EBITDA margin is 4.30%, and its revenue ttm is $85.09 Billion , which makes it $146.30 revenue per share.
Of the last four earnings reports from Centene Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $1.49 for the next earnings report. Centene Corporation’s next earnings report date is 27th Apr 2021.
The consensus rating of Wall Street analysts for Centene Corporation is Strong Buy (1.03), with a target price of $78.73, which is +21.20% compared to the current price. The earnings rating for Centene Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Centene Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Centene Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 7.69, ATR14 : 1.70, CCI20 : 68.64, Chaikin Money Flow : 0.04, MACD : 0.92, Money Flow Index : 47.78, ROC : -0.64, RSI : 67.29, STOCH (14,3) : 72.96, STOCH RSI : 1.00, UO : 54.48, Williams %R : -27.04), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Centene Corporation in the last 12-months were: Brandy Burkhalter (Sold 32 000 shares of value $2 144 000 ), Jesse N. Hunter (Sold 33 750 shares of value $2 362 500 ), John R. Roberts (Sold 25 000 shares of value $1 725 000 ), Kenneth A. Burdick (Sold 280 000 shares of value $18 299 050 ), Michael F. Neidorff (Sold 300 000 shares of value $21 036 000 ), Orlando Ayala (Sold 86 768 shares of value $5 507 876 ), Richard A. Gephardt (Sold 50 300 shares of value $3 278 176 ), Robert K. Ditmore (Buy at a value of $9 937), Robert K. Ditmore (Sold 133 333 shares of value $8 702 310 ), Tommy G. Thompson (Sold 4 500 shares of value $279 930 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. After acquiring WellCare in early 2020, Centene serves nearly 25 million members, mostly in Medicaid (13 million), Medicare (5 million total, including 4 million in Part D plans and 1 million in Medicare Advantage), the individual exchanges (2 million), and other plans (4 million), including Tricare (West region), correctional facility, and international plans.
CEO: Michael F. Neidorff
Telephone: +1 314 725-4477
Address: 7700 Forsyth Boulevard, St. Louis 63105, MO, US
Number of employees: 71 300
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE BZX (BATS) real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2021. All market data is provided by Barchart Solutions. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.